Die SURMOUNT-1-Studie [8] umfasste 2539 bergewichtige Probanden, die ber 72 Wochen 5, 10 oder 15 mg Tirzepatid im Vergleich zu Placebo erhielten
We defined psychiatric comorbidity as having alcohol and substance abuse (ICD-10: F10-F19), schizophrenia (ICD-10: F20-F29), bipolar disorders (ICD-10: F30-F31), major depression (ICD-10: F32-F33), eating disorders (ICD-10: F50), personality disorders (ICD-10: F60-F62) and psychotropics within 10 years prior to index date ( See Supplementary Table 1)
A well-structured meal plan helps you overcome these challenges, ensuring you meet your health goals
Studies from Novo Nordisk show an almost 25% reduction in adverse kidney outcomes for diabetes patients with CKD, and the company is trying to get Wegovys indications expanded to include CKD before years end
But you do not have to wait for large clinical trials to understand how the drug affects your migraines specifically
Preclinical research in animal models has identified GLP-1 receptors in synovial tissue, cartilage, and bone, suggesting potential for direct effects on joint structures